genprowebdirectory
GEN Edge
Video & Multimedia
Latest News
Login
Subscribe
News
Insights
Trends for 2020
Trends for 2021
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
GEN Protocols
Resources
Summits
Webinars
GEN Live
eBooks/Perspectives
Podcasts
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
– INSIDE –
PRECISION MEDICINE
Search
About GEN
Contact GEN
Update Preferences
Subscribe
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Video & Multimedia
Latest News
Login
Subscribe
News
Allergic Diseases
Corneal T Cells Produce Limited Immune Response to Protect Eyes from…
Artificial Intelligence
Which SARS-CoV-2 Variant Will Cause the Next Wave? An AI Tool…
Circadian Rhythm
Fetal Master Clock Genes Dance to Mother’s Beat
Cancer
Simple Treatment May Prevent Long-Term Side Effects of Cancer Radiotherapy
Bacterial Diseases
Novel Method Developed to Reduce Risk of Bacterial Infection in Cystic…
Insights
All
Trends for 2020
Trends for 2021
Bioprocessing
Tissue Biomanufacturing Progresses, but Still a Way to Go
Bioprocessing
Training Bioprocessors with Virtual Reality
Bioprocessing
Groundwork Established for Continuous Monitoring
Bioprocessing
Holographic Microscopy Helping Biopharma Keep an Eye on Cell Culture
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
A-Lists
Seven Biopharma Trends to Watch in 2022
A-Lists
Six of the Best Reports from the Front Line of Biotechnology
A-Lists
Top 10 RNA-Based Biopharmas
Magazine
Current Issue
Past Issues
Supplements
Subscribe
GEN Protocols
Resources
Summits
Webinars
GEN Live
eBooks/Perspectives
Podcasts
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
– INSIDE –
PRECISION MEDICINE
Home
Antibodies
Monoclonal Antibodies
Page 35
Monoclonal Antibodies
Antibody Drug Conjugates
Bispecific Antibodies
Epitope Mapping
Monoclonal Antibodies
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Monoclonal Antibodies
Investment and Technology Key to 24/7 Continuous Production
Monoclonal Antibodies
Horizon Therapeutics to Expand Pipeline, R&D with $3B Viela Bio Acquisition
Monoclonal Antibodies
OncoMethylome to Carry Out MGMT Assay as Part of Roche’s Phase III Avastin Trial in Glioblastoma
Monoclonal Antibodies
FDA Imposes Partial Holds on Five Gilead Trials of Cancer Candidate
Monoclonal Antibodies
BI Taps MacroGenics in Multibillion-Dollar Deal for Antibody Development
Monoclonal Antibodies
Apeiron Gains Rights to Phase III-Stage Neuroblastoma Treatment
Monoclonal Antibodies
Stanford Spinout Partners with Merck KGaA, Genentech in Cancer Studies of...
Monoclonal Antibodies
Discovery of Rapidly Adapting Antibody Opens Door for Universal Flu Vaccines
Monoclonal Antibodies
Effimune, In Cell Art Launch Cancer Immunotherapy Collaboration
Monoclonal Antibodies
Sex Hormone-Synthesis Gene Linked to Eczema
Monoclonal Antibodies
Protein Titer Monitoring through Index of Refraction
Monoclonal Antibodies
Developing Chicken-Derived mAbs
Monoclonal Antibodies
Aveo Signs BI on as Production Partner for Clinical-Stage mAb
Monoclonal Antibodies
Whence the Facility Expansions?
Monoclonal Antibodies
OncoImmune Licenses ONC-392 to Pfizer for Up to $250M
1
...
34
35
36
37
Page 35 of 37
Scroll Up
![Firm will get $60 million over the first three years to use its DART platform.[Sebastian Kaulitzki-Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/UGENWebsitepicturesTopStoriesOct2010Oct26_2010_8300503_AntibodiesBlood_BIandMacroGenicsAntibodyDeal1151433122-265x198.jpg "BI Taps MacroGenics in Multibillion-Dollar Deal for Antibody Development")
![Mouse-Human chimeric mAb targeting GD2 was developed by CCRI and SIOPEN.[© Francois du Plessis - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/June22_2011_346419_BabyInHospital_ApeironNeuroblastoma2282551982-324x160.jpg "Apeiron Gains Rights to Phase III-Stage Neuroblastoma Treatment")
